BMPR2 and pulmonary arterial hypertension: Multiple lines of evidence showed that BMPR2 presence in pulmonary arteries is a critical determinant of PAH, as both the gene mutations and its low expression are tightly associated with disease pathogenesis, progression, and outcomes [15,49,254,255].